Department of Health and Human Services, Food and Drug Administration
Clinical Trials Addressing Unmet Needs of Rare Neurodegenerative Diseases (R01) Clinical Trials Required
Who can apply
- City or township governments
- Independent school districts
- County governments
- For-profit organizations (not small businesses)
- Small businesses
- Unrestricted
- Tribal organizations
- Nonprofits with 501(c)(3) status
- Public and state-controlled colleges
- Special district governments
- Private colleges and universities
- Nonprofits without 501(c)(3) status
- State governments
- Federally recognized tribal governments
- Public and tribal housing authorities
About this grant
The purpose is to fund clinical trials of products evaluating efficacy and/or safety in support of a new indication or change in labeling to address unmet needs in rare neurodegenerative diseases for children and adults. Through the support of collaborative, efficient, and/or innovative clinical trials, FDA expects to increase the number of approved treatments for rare neurodegenerative diseases and exert a broad and positive impact on rare disease drug development.
Program history
Topics
GrantCalendar is not affiliated with Department of Health and Human Services. Details can change, so confirm everything on the official listing before you apply. Spotted a mistake? Tell us.
Similar open grants
- Closes Jan 29, 2027
- Closes Sep 4, 2028
- Closes Jan 11, 2028
- Closes Apr 1, 2027
- Closes May 12, 2028
Get new grants every Monday
One short email with new grants and deadlines coming up in the next two weeks. Unsubscribe in one click.